3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
7
Rectal Neoplasms
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Sarcopenia
1
Sarcoglycanopathies
1
Peritoneal Neoplasms
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Pancreatic Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Mesothelioma
1
Melanoma
1
Malnutrition
1
Lung Neoplasms
1
HER2 Negative Breast Cancer
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Frailty
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
maltodextrin
2
Resistance Training
2
Exercise
2
pembrolizumab
1
nicotinamide-beta-riboside
1
durvalumab
1
atezolizumab
1
Wearable Electronic Devices
1
Standard of Care
1
Relaxation Therapy
1
Nutrition Therapy
1
Nutrition Assessment
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Glutamine
1
Gloves, Surgical
1
Geriatric Assessment
1
Creatine
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Caloric Restriction
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcopenia
×
Chemotherapy, Adjuvant
×
1 year
×
Clear all
NCT07184047
2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
72 enrolled